Development of Targeted Therapies in High Risk Childhood Acute Lymphoblastic Leukemia |
Children’s Hospital of Philadelphia / Sarah Tasian |
Young Investigator Grants |
2012 |
Pennsylvania |
Development of An Innovative Treatment Strategy for Neuroblastoma and Other Pediatric Tumors: A Novel Phospholipid Ester Analogue and its Multifunctional Cancer-targeting Nanoconstruct |
University of Wisconsin - Madison / Mario Otto |
Young Investigator Grants |
2012 |
Wisconsin |
Treatment for human hepatoblastoma based on recombinant adeno-associated virus vectors |
University of Florida / Chen Ling |
Young Investigator Grants |
2012 |
Florida |
SWI/SNF Complex and Glucocorticoid Resistance in Pediatric Acute Lymphoblastic Leukemia |
Dana-Farber Cancer Institute / Jennifer Wu |
Young Investigator Grants |
2012 |
Massachusetts |
Transcriptome Sequencing (RNA-Seq) for Identification of Novel Markers of Disease Outcome and Therapeutic Targets in Acute Myeloid Leukemia |
Fred Hutchinson Cancer Research Center / Fabiana Ostronoff, MD |
Young Investigator Grants |
2012 |
Washington |
Small-molecule screening for novel pediatric glioma radiosensitizers. |
Yale School of Medicine / Ranjit Bindra |
Young Investigator Grants |
2012 |
Connecticut |
Determinants of Testicular Germ Cell Tumor Platinum Sensitivity and Resistance |
University of California, San Diego / Paolo Abada |
Young Investigator Grants |
2012 |
California |
Screening for New Rhabdomyosaroma Pathogenesis Genes in a Drosophila Model |
University of Texas Southwestern Medical Center / Kathleen Galindo |
Young Investigator Grants |
2012 |
Texas |
Selective inhibition of nuclear export as a novel therapeutic strategy in AML |
Dana-Farber Cancer Institute / Julia Etchin |
Young Investigator Grants |
2012 |
Massachusetts |
V alpha-invariant NKT cells as a novel platform for cancer immunotherapy |
Baylor College of Medicine / Leonid Metelitsa, MD, PhD |
Innovation Grants |
2012 |
Texas |